VTRS
VTRS
NASDAQ · Pharmaceuticals

Viatris Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$15.95
+0.03 (+0.19%)
As of Feb 24, 1:08 PM ET ·
Financial Highlights (FY 2026)
Revenue
14.05B
Net Income
-604,370,981
Gross Margin
41.6%
Profit Margin
-4.3%
Rev Growth
-6.3%
D/E Ratio
0.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 41.6% 41.6% 35.8% 35.8%
Operating Margin -4.1% -3.7% 29.8% 37.8%
Profit Margin -4.3% -4.1% 27.9% 27.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.05B 14.98B 3.47B 3.37B
Gross Profit 5.85B 6.24B 1.24B 1.20B
Operating Income -574,447,544 -551,469,642 1.03B 1.27B
Net Income -604,370,981 -580,196,141 966.90M 917.66M
Gross Margin 41.6% 41.6% 35.8% 35.8%
Operating Margin -4.1% -3.7% 29.8% 37.8%
Profit Margin -4.3% -4.1% 27.9% 27.3%
Rev Growth -6.3% -6.3% -2.8% +22.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.90B 3.90B 4.37B 3.63B
Total Equity 5.17B 5.17B 12.59B 11.78B
D/E Ratio 0.75 0.75 0.35 0.31
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 2.69B 2.72B 1.51B 1.62B
Free Cash Flow — — 925.81M 1.00B